Market sentiment signals for ADMA Biologics (ADMA): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
5 analysts
Options Flow (P/C)
—
Avg Consensus PT
$23
+126.4%
Highest Price Target
$32
+211.6%
Lowest Price Target
$17
+65.5%
Short Interest
11.3%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | Mizuho | Anthony Petrone— | +65.5% | $20 → $17 | Maintained | Outperform |
| May 7, 2026 | Canaccord Genuity | Gary Nachman— | +75.3% | $21 → $18 | Maintained | Buy |
